A 'danse macabre': Tau and Fyn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity

European Journal of Neuroscience

Volumn 37, Issue 12, 2013, Pages 1925-1930

  Boehm, Jannic ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alzheimer disease; Kinase; NMDA receptors; Plasticity; Signal transduction; Synaptic

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE FYN; PROTEIN STEP; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; DENDRITIC CELL; EXCITOTOXICITY; HIPPOCAMPAL CA1 REGION; HUMAN; LONG TERM POTENTIATION; NERVE CELL DEGENERATION; NERVE CELL INHIBITION; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL DEATH; LONG-TERM SYNAPTIC DEPRESSION; MICE; NEURONAL PLASTICITY; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, N-METHYL-D-ASPARTATE; TAU PROTEINS;

EID: 84879217258     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12251     Document Type: Review

References (64)

1. Barry, A.E., Klyubin, I., Mc Donald, J.M., Mably, A.J., Farrell, M.A., Scott, M., Walsh, D.M. & Rowan, M.J. (2011) Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J. Neurosci., 31, 7259-7263.
2. Bhaskar, K., Yen, S.H. & Lee, G. (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J. Biol. Chem., 280, 35119-35125.
3. Chin, J., Palop, J.J., Puolivali, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E. & Mucke, L. (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci., 25, 9694-9703.
4. Chittajallu, R., Alford, S. & Collingridge, G.L. (1998) Ca2+ and synaptic plasticity. Cell Calcium, 24, 377-385.
5. Cisse, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D.B., Sun, B., Orr, A., Lotz, G., Kim, D.H., Hamto, P., Ho, K., Yu, G.Q. & Mucke, L. (2011) Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature, 469, 47-52.
6. Collingridge, G.L., Isaac, J.T. & Wang, Y.T. (2004) Receptor trafficking and synaptic plasticity. Nat. Rev. Neurosci., 5, 952-962.
7. Gong, Y., Chang, L., Viola, K.L., Lacor, P.N., Lambert, M.P., Finch, C.E., Krafft, G.A. & Klein, W.L. (2003) Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA, 100, 10417-10422.
8. Grant, S.G., O'Dell, T.J., Karl, K.A., Stein, P.L., Soriano, P. & Kandel, E.R. (1992) Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science, 258, 1903-1910.
9. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M. & Binder, L.I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA, 83, 4913-4917.
10. Hanger, D.P., Anderton, B.H. & Noble, W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med., 15, 112-119.
11. Hardy, J. & Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356.
12. Hoover, B.R., Reed, M.N., Su, J., Penrod, R.D., Kotilinek, L.A., Grant, M.K., Pitstick, R., Carlson, G.A., Lanier, L.M., Yuan, L.L., Ashe, K.H. & Liao, D. (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron, 68, 1067-1081.
13. Hsia, A.Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R.C., Nicoll, R.A. & Mucke, L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA, 96, 3228-3233.
14. Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S. & Malinow, R. (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron, 52, 831-843.
15. Ingelsson, M., Fukumoto, H., Newell, K.L., Growdon, J.H., Hedley-Whyte, E.T., Frosch, M.P., Albert, M.S., Hyman, B.T. & Irizarry, M.C. (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology, 62, 925-931.
16. Ittner, L.M., Ke, Y.D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wolfing, H., Chieng, B.C., Christie, M.J., Napier, I.A., Eckert, A., Staufenbiel, M., Hardeman, E. & Gotz, J. (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell, 142, 387-397.
17. Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D. & Selkoe, D.J. (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc. Natl. Acad. Sci. USA, 108, 5819-5824.
18. Jo, J., Whitcomb, D.J., Olsen, K.M., Kerrigan, T.L., Lo, S.C., Bru-Mercier, G., Dickinson, B., Scullion, S., Sheng, M., Collingridge, G. & Cho, K. (2011) Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat. Neurosci., 14, 545-547.
19. Johnson, G.V. & Hartigan, J.A. (1999) Tau protein in normal and Alzheimer's disease brain: an update. J. Alzheimers Dis., 1, 329-351.
20. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S. & Malinow, R. (2003) APP processing and synaptic function. Neuron, 37, 925-937.
21. Kessels, H.W., Nguyen, L.N., Nabavi, S. & Malinow, R. (2010) The prion protein as a receptor for amyloid-beta. Nature, 466, E3-E4; discussion E4-5.
22. Kessels, H.W., Nabavi, S. & Malinow, R. (2013) Metabotropic NMDA receptor function is required for beta-amyloid-induced synaptic depression. Proc. Natl. Acad. Sci. USA, 110, 4033-4038.
23. Kurup, P., Zhang, Y., Xu, J., Venkitaramani, D.V., Haroutunian, V., Greengard, P., Nairn, A.C. & Lombroso, P.J. (2010) Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61. J. Neurosci., 30, 5948-5957.
24. Lauren, J., Gimbel, D.A., Nygaard, H.B., Gilbert, J.W. & Strittmatter, S.M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature, 457, 1128-1132.
25. Lavezzari, G., McCallum, J., Lee, R. & Roche, K.W. (2003) Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology, 45, 729-737.
26. Ledford, H. (2010) Key Alzheimer's findings questioned. Nature, 466, 1031.
27. Lee, S.H., Liu, L., Wang, Y.T. & Sheng, M. (2002) Clathrin adaptor AP2 and NSF interact with overlapping sites of GluR2 and play distinct roles in AMPA receptor trafficking and hippocampal LTD. Neuron, 36, 661-674.
28. Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M. & Ashe, K.H. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature, 440, 352-357.
29. Li, S., Hong, S., Shepardson, N.E., Walsh, D.M., Shankar, G.M. & Selkoe, D. (2009) Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron, 62, 788-801.
30. Li, Z., Jo, J., Jia, J.M., Lo, S.C., Whitcomb, D.J., Jiao, S., Cho, K. & Sheng, M. (2010) Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell, 141, 859-871.
31. Lu, Y.F., Kojima, N., Tomizawa, K., Moriwaki, A., Matsushita, M., Obata, K. & Matsui, H. (1999) Enhanced synaptic transmission and reduced threshold for LTP induction in fyn-transgenic mice. Eur. J. Neurosci., 11, 75-82.
32. Lue, L.F., Kuo, Y.M., Roher, A.E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J.H., Rydel, R.E. & Rogers, J. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol., 155, 853-862.
33. Malinow, R. (2012) New developments on the role of NMDA receptors in Alzheimer's disease. Curr. Opin. Neurobiol., 22, 559-563.
34. Malinow, R. & Malenka, R.C. (2002) AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci., 25, 103-126.
35. Mondragon-Rodriguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N. & Boehm, J. (2012) Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-d-aspartate receptor-dependent tau phosphorylation. J. Biol. Chem., 287, 32040-32053.
36. Murrell, J., Farlow, M., Ghetti, B. & Benson, M.D. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science, 254, 97-99.
37. Nguyen, T.H., Liu, J. & Lombroso, P.J. (2002) Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J. Biol. Chem., 277, 24274-24279.
38. O'Nuallain, B., Freir, D.B., Nicoll, A.J., Risse, E., Ferguson, N., Herron, C.E., Collinge, J. & Walsh, D.M. (2010) Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils. J. Neurosci., 30, 14411-14419.
39. Peineau, S., Taghibiglou, C., Bradley, C., Wong, T.P., Liu, L., Lu, J., Lo, E., Wu, D., Saule, E., Bouschet, T., Matthews, P., Isaac, J.T., Bortolotto, Z.A., Wang, Y.T. & Collingridge, G.L. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron, 53, 703-717.
40. Pelkey, K.A., Askalan, R., Paul, S., Kalia, L.V., Nguyen, T.H., Pitcher, G.M., Salter, M.W. & Lombroso, P.J. (2002) Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron, 34, 127-138.
41. Renner, M., Lacor, P.N., Velasco, P.T., Xu, J., Contractor, A., Klein, W.L. & Triller, A. (2010) Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron, 66, 739-754.
42. Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.Q. & Mucke, L. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science, 316, 750-754.
43. Roberson, E.D., Halabisky, B., Yoo, J.W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G.Q., Palop, J.J., Noebels, J.L. & Mucke, L. (2011) Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J. Neurosci., 31, 700-711.
44. Roche, K.W., Standley, S., McCallum, J., Dune Ly, C., Ehlers, M.D. & Wenthold, R.J. (2001) Molecular determinants of NMDA receptor internalization. Nat. Neurosci., 4, 794-802.
45. Salter, M.W. & Kalia, L.V. (2004) Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci., 5, 317-328.
46. Selkoe, D.J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 81, 741-766.
47. Selkoe, D.J. (2002) Alzheimer's disease is a synaptic failure. Science, 298, 789-791.
48. Selkoe, D.J. & Schenk, D. (2003) Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol., 43, 545-584.
49. Shankar, G.M., Bloodgood, B.L., Townsend, M., Walsh, D.M., Selkoe, D.J. & Sabatini, B.L. (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci., 27, 2866-2875.
50. Sheng, M. & Kim, M.J. (2002) Postsynaptic signaling and plasticity mechanisms. Science, 298, 776-780.
51. Shipton, O.A., Leitz, J.R., Dworzak, J., Acton, C.E., Tunbridge, E.M., Denk, F., Dawson, H.N., Vitek, M.P., Wade-Martins, R., Paulsen, O. & Vargas-Caballero, M. (2011) Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J. Neurosci., 31, 1688-1692.
52. Snyder, E.M., Nong, Y., Almeida, C.G., Paul, S., Moran, T., Choi, E.Y., Nairn, A.C., Salter, M.W., Lombroso, P.J., Gouras, G.K. & Greengard, P. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci., 8, 1051-1058.
53. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P.A., Waridel, C., Calhoun, M.E., Jucker, M., Probst, A., Staufenbiel, M. & Sommer, B. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA, 94, 13287-13292.
54. Tamburri, A., Dudilot, A., Licea, S., Bourgeois, C. & Boehm, J. (2013) NMDA-receptor activation but not ion flux is required for amyloid-beta induced synaptic depression. PLOS One, in press.
55. Trepanier, C.H., Jackson, M.F. & MacDonald, J.F. (2012) Regulation of NMDA receptors by the tyrosine kinase Fyn. FEBS J., 279, 12-19.
56. Um, J.W., Nygaard, H.B., Heiss, J.K., Kostylev, M.A., Stagi, M., Vortmeyer, A., Wisniewski, T., Gunther, E.C. & Strittmatter, S.M. (2012) Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. Neurosci., 15, 1227-1235.
57. Van der Jeugd, A., Hochgrafe, K., Ahmed, T., Decker, J.M., Sydow, A., Hofmann, A., Wu, D., Messing, L., Balschun, D., D'Hooge, R. & Mandelkow, E.M. (2012) Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathol., 123, 787-805.
58. Wang, H.Y., Lee, D.H., D'Andrea, M.R., Peterson, P.A., Shank, R.P. & Reitz, A.B. (2000) beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem., 275, 5626-5632.
59. Yang, K., Trepanier, C., Sidhu, B., Xie, Y.F., Li, H., Lei, G., Salter, M.W., Orser, B.A., Nakazawa, T., Yamamoto, T., Jackson, M.F. & Macdonald, J.F. (2012) Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases. EMBO J., 31, 805-816.
60. Zempel, H. & Mandelkow, E.M. (2012) Linking amyloid-beta and tau: amyloid-beta induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton. Neurodegener. Dis., 10, 64-72.
61. Zempel, H., Thies, E., Mandelkow, E. & Mandelkow, E.M. (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci., 30, 11938-11950.
62. Zhang, Y., Venkitaramani, D.V., Gladding, C.M., Zhang, Y., Kurup, P., Molnar, E., Collingridge, G.L. & Lombroso, P.J. (2008) The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J. Neurosci., 28, 10561-10566.
63. Zhang, Y., Kurup, P., Xu, J., Carty, N., Fernandez, S.M., Nygaard, H.B., Pittenger, C., Greengard, P., Strittmatter, S.M., Nairn, A.C. & Lombroso, P.J. (2010) Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. USA, 107, 19014-19019.
64. Zhou, Q., Homma, K.J. & Poo, M.M. (2004) Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron, 44, 749-757.